Amplius Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
LMFP
ATO
HCM
AAMU
FWCM
Amplius Wealth Advisors's ABBV Position: Q2 2026 in Review
Amplius Wealth Advisors increased its AbbVie (ABBV) stake by 38% in Q2 2026, buying an estimated $193K and bringing the position to 3,241 shares worth $816K. The position accounts for 0.06% of the portfolio, ranked #87.
Amplius Wealth Advisors first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.13M in Q4 2021. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Amplius Wealth Advisors held 3,241 shares of AbbVie worth $816K as of Q2 2026.
- Amplius Wealth Advisors bought 897 AbbVie shares in Q2 2026, an estimated $193K.
- AbbVie made up 0.06% of Amplius Wealth Advisors's portfolio in Q2 2026, its #87 holding.
- Amplius Wealth Advisors first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- Amplius Wealth Advisors's AbbVie position peaked at $1.13M in Q4 2021.
- 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Amplius Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.